Newly approved blood thinner may increase susceptibility to some viral infections
Monday, April 1, 2013 - 12:30
in Health & Medicine
A new study indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.